Abstract
To elucidate control mechanisms ofO-glycan biosynthesis in leukemia and to develop biosynthetic inhibitors we have characterized core 2 UDP-GlcNAc:Galβ1-3GalNAc-R(GlcNAc to GalNAc) β6-N-acetylglucosaminyl-transferase (EC 2.4.1.102; core 2 β6-GlcNAc-T) and CMP-sialic acid: Galβ1-3GalNAc-R α3-sialyltransferase (EC 2.4.99.4; α3-SA-T), two enzymes that are significantly increased in patients with chronic myelogenous leukemia (CML) and acute myeloid leukemia (AML). We observed distinct tissue-specific kinetic differences for the core 2 β6-GlcNAc-T activity; core 2 β6-GlcNAc-T from mucin secreting tissue (named core 2 β6-GlcNAc-T M) is accompanied by activities that synthesize core 4 [GlcNAcβ1-6(GlcNAcβ1-3)GalNAc-R] and blood group I [GlcNAcβ1-6(GlcNAcβ1-3)Galβ-R] branches; core 2 β6-GlcNAc-T in leukemic cells (named core 2 β-GlcNAc-T L) is not accompanied by these two activities and has a more restricted specificity. Core 2 β6-GlcNAc-T M and L both have an absolute requirement for the 4- and 6-hydroxyls ofN-acetylgalactosamine and the 6-hydroxyl of galactose of the Galβ1-3GalNAcα-benzyl substrate but the recognition of other substituents of the sugar rings varies, depending on the tissue. α3-sialytransferase from human placenta and from AML cells also showed distinct specificity differences, although the enzymes from both tissues have an absolute requirement for the 3-hydroxyl of the galactose residue of Galβ1-3GalNAcα-Bn. Galβ1-3(6-deoxy)GalNAcα-Bn and 3-deoxy-Galβ1-3GalNAcα-Bn competitively inhibited core 2 β6-GlcNAc-T and α3-sialyltransferase activities, respectively.
Similar content being viewed by others
Abbreviations
- AFGP:
-
antifreeze glycoprotein
- AML:
-
acute myeloid leukemia
- Bn:
-
benzyl
- CML:
-
chronic myelogenous leukemia
- Fuc:
-
l-fucose
- Gal, G:
-
d-galactose
- GalNAc, GA:
-
N-acetyl-d-galactosamine
- GlcNAc, Gn:
-
N-acetyl-d-glucosamine
- HC:
-
human colonic homogenate
- HO:
-
hen oviduct microsomes
- HPLC:
-
high performance liquid chromatography
- mco:
-
8-methoxycarbonyl-octy
- Me:
-
methyl
- MES:
-
2-(N-morpholino)ethanesulfonate
- MK:
-
mouse kidney homogenate
- onp:
-
o-nitrophenyl
- PG:
-
pig gastric mucosal microsomes
- pnp:
-
p-nitrophenyl
- RC:
-
rat colonic mucosal microsomes
- SA:
-
sialic acid
- T:
-
transferase
References
Carlsson SR, Sasaki H, Fukuda M (1986)J Biol Chem 261:12787–95.
Fukuda M, Carlsson SR, Klock JC, Dell A (1986)J Biol Chem 261:12796–806.
Saitoh O, Piller F, Fox RI, Fukuda M (1991)Blood 77:1491–9.
Saitoh O, Gallegher RE, Fukuda M (1991)Cancer Res 51:2854–62.
Fukuda M (1991)Glycobiology 1:347–56.
Schachter H, Brockhausen I (1992) InGlycoconjugates, Composition, Structure and Function, pp 263–331 (Allen H, Kisailus, EC, Eds) New York: Marcel Dekker.
Kuhns W, Oliver R, Watkins W, Greenwell P (1980)Cancer Res 40:268–75.
Brockhausen I, Kuhns W, Schachter H, Matta KL, Sutherland DR, Baker MA (1991)Cancer Res. 51:1257–63.
Baker MA, Taub RN, Kanani A, Brockhausen I, Hindenburg A (1985)Blood 66:1068–71.
Baker MA, Kanani A, Brockhausen I, Schachter H, Hindenburg A, Taub RN (1987)Cancer Res 47:2763–6.
Kanani A, Sutherland DR, Fibach E, Matta KL, Hindenburg A, Brockhausen I, Kuhns W, Taub RN, van den Eijnden DH, Baker MA (1990)Cancer Res 50:5003–7.
Williams D, Schachter H (1980)J Biol Chem 255:11247–52.
Williams D, Longmore G, Matta KL, Schachter H (1980)J Biol Chem 255:11253–61.
Wingert WE, Cheng P-W (1984)Biochemistry 23:690–7.
Brockhausen I, Matta KL, Orr J, Schachter H (1985)Biochemistry 24:1866–74.
Brockhausen I, Matta KL, Orr J, Schachter H. Koenderman A, van den Eijnden DH (1986)Eur J Biochem 157:463–74.
Cheng P-W, Wingert WE, Little MR, Wei R (1985)Biochem J 227:405–12.
Ropp PA, Little MR, Cheng P-W (1991)J Biol Chem 266:23863–71.
Bierhuizen MA, Fukuda M (1992)Proc Nat Acad Sci USA 89:9326–30.
Brockhausen I, Romero PA, Herscovics A (1991)Cancer Res. 51:3136–42.
Piller F. Piller V, Fox R, Fukuda M (1988)J Biol Chem 263:15146–50.
Higgins EA, Siminovitch KA, Zhuang D, Brockhausen I, Dennis JW (1991)J Biol Chem 266:6280–90.
Piller F. Le Deist F, Weinberg KI, Parkman R, Fukuda M (1991)J Exp Med 173:1501–10.
Yousefi S, Higgins E, Zhuang D, Pollex-Krüger A, Hindsgaul O, Dennis JW (1991)J Biol Chem 266:1772–82.
Piller F, Cartron J-P, Maranduba A, Veyrières A, Leroy Y, Fournet B (1984)J Biol Chem 259:13385–90.
Sadler JE, Rearick JI, Paulson JC, Hill RL (1979)J Biol Chem 254:4434–43.
Rearick JI, Sadler JE, Paulson JC, Hill RL (1979)J Biol Chem 254:4444–51.
Joziasse DH, Bergh MLE, Ter Hart H, Koppen PL, Hooghwinkel GJM, van den Eijnden DH (1985)J Biol Chem 260:4941–51.
Bergh MLE, Hooghwinkel GJM, van den Eijnden DH (1981)Biochim Biophys Acta 660:161–9.
Gillespie W, Kelm S, Paulson JC (1992)J Biol Chem 267:21004–10.
Paulsen H, van Deessen U (1988)Carbohydr Res 175:283–93.
Paulsen H, Rutz V, Brockhausen I (1992)Liebigs Ann Chem 747–58.
Ratcliffe RM, Baker DA, Lemieux RU (1981)Carbohydr Res 93:35–41.
Paulsen H, Hölk JP (1982)Carbohydr Res 109:89–107.
Paulsen H, Adermann K (1989)Liebigs Ann Chem 751–80.
Rana SS, Barlow JJ, Matta KL (1981)Carbohydr Res 96:231–9.
Piscorz CF, Abbas SA, Matta KL (1984)Carbohydr Res 126:115–24.
Piscorz CF, Abbas SA, Matta KL (1984)Carbohydr Res 131:257–63.
Matta KL, Barlow JJ (1976)Carbohydr Res 48:65–71.
Flowers HM, Shapiro D (1965)J Org Chem 30:2041–3.
Abbas SA, Barlow JJ, Matta KL (1983)Carbohydr Res 112:201–11.
Paulsen H, Rutz V, Brockhausen I (1992)Liebigs Ann Chem 735–45.
Brockhausen I, Möller G, Pollex-Krüger A, Rutz V, Paulsen H, Matta KL (1992)Biochem Cell Biol 70:99–108.
Brockhausen I, Carver JP, Schachter H (1988)Biochem Cell Biol 66:1134–51.
Brockhausen I, Grey AA, Pang H, Schachter H, Carver JP (1988)Glycoconjugate J 5:419–48.
Ciucanu I, Kerek F (1984)Carbohydr Res 131:209–17.
Bradford M (1976)Anal Biochem 72:248.
Oistler JJ, Jourdian GW (1973)J Biol Chem 248:6772–80.
Pollex-Krüger A, Meyer B, Stuike-Prill R, Sinnwell V, Matta KL, Brockhaussen I (1993)Glycoconjugate J 10:in press.
Bierhuizen MFA, Mattei M-G, Fukuda M. (1993)Genes Development, in press.
Hindsgaul O, Kaur KJ, Srivastava G, Glasczyk-Thurin M, Crawley SC, Heerze LD, Palcic MM (1991)J Biol Chem 266:17858–62.
Gu J, Nishikawa A, Fujii S, Gasa S, Taniguchi N (1992)J Biol Chem 267:2994–9.
Sekine M, Hashimoto Y, Inagaki F, Yamakawa T, Suzuki A (1990)J. Biochem (Tokyo) 108:103–8.
Basu M, Basu S (1984)J Biol Chem 259:12557–62.
Koenderman AHL, Koppen PL, van den Eijnden DH (1987)Eur J Biochem 166:199–208.
Leppänen A, Penttilä L, Niemelä R, Helin J, Seppo A, Lusa S, Renkonen O (1991)Biochemistry 30:9287–96.
Author information
Authors and Affiliations
Additional information
Enzymes: UDP-GlcNAc:Galβ1-3GalNAc-R (GlcNAc to GalNAc) β6-N-acetylglucosaminyltransferase,O-glycan core 2 β6-GlcNAc-transferase, EC 2.4.1.102; CMP-sialic acid: Galβ1-3GalNAc-R α3-sialyltransferase,O-glycan α3-sialic acid-transferase, EC 2.4.99.4.
Rights and permissions
About this article
Cite this article
Kuhns, W., Rutz, V., Paulsen, H. et al. ProcessingO-glycan core 1, Galβ1-3GalNAcα-R. Specificities of core 2, UDP-GlcNAc: Galβ1-3GalNAc-R(GlcNAc to GalNAc) β6-N-acetylglucosaminyltransferase and CMP-sialic acid:Galβ1-3GalNAc-R α3-sialyltransferase. Glycoconjugate J 10, 381–394 (1993). https://doi.org/10.1007/BF00731043
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00731043